Cargando…
Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration
PURPOSE: The development and testing of key questions suitable to identify patients’ difficulties with medication administration. MATERIALS AND METHODS: We used a consecutive five-step process to draft key questions regarding 43 aspects of medication administration that can be difficult for patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579958/ https://www.ncbi.nlm.nih.gov/pubmed/34785891 http://dx.doi.org/10.2147/PPA.S328380 |
_version_ | 1784596525474643968 |
---|---|
author | Wurmbach, Viktoria S Schmidt, Steffen J Lampert, Anette Bernard, Simone Faller, Christine K Thürmann, Petra A Haefeli, Walter E Seidling, Hanna M |
author_facet | Wurmbach, Viktoria S Schmidt, Steffen J Lampert, Anette Bernard, Simone Faller, Christine K Thürmann, Petra A Haefeli, Walter E Seidling, Hanna M |
author_sort | Wurmbach, Viktoria S |
collection | PubMed |
description | PURPOSE: The development and testing of key questions suitable to identify patients’ difficulties with medication administration. MATERIALS AND METHODS: We used a consecutive five-step process to draft key questions regarding 43 aspects of medication administration that can be difficult for patients who manage a complex drug treatment: Step 1) Identification of potentially error-prone characteristics of drug treatment (such as certain dosage forms) and initial draft of key questions. Step 2) Assessment of how comprehensible the questions are for patients. Step 3) Pre-testing of exemplary key questions with patients and monitoring of patient’s actual medication administration behavior. Step 4) Evaluation by general practitioners of how well the questions may be integrated into actual patient visits. Step 5) Final approval of the questions in an expert panel. Thereafter, we pilot-tested exemplary questions with 36 patients (43 tests). In the course of this pilot-testing, the patients’ answers to the key questions were tested against both their actual behavior during medication administration and against their answers to more general questions regarding potential difficulties with medication administration. RESULTS: More than half of the key questions (N = 24/43) were revised at least once during the development process. During the pilot-testing, 55.8% of the pilot-tests (N = 24/43) revealed medication administration difficulties. It was observed that the key questions identified significantly more difficulties (N = 17) than the general questions (N = 8; P = 0.021, positive predictive value = 94.4% vs 88.9%). In one case, both a key question and a general question identified difficulties, which, however, was not confirmed during the drug administration demonstration, indicating a false positive rate of 5.3% in both cases. CONCLUSION: We developed key questions aimed at detecting administration errors with a high specificity and a significantly higher sensitivity than general questions, suggesting that the resource-intensive demonstration of medication administration can be reserved for the detection of rarer and uncommon administration errors. |
format | Online Article Text |
id | pubmed-8579958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85799582021-11-15 Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration Wurmbach, Viktoria S Schmidt, Steffen J Lampert, Anette Bernard, Simone Faller, Christine K Thürmann, Petra A Haefeli, Walter E Seidling, Hanna M Patient Prefer Adherence Original Research PURPOSE: The development and testing of key questions suitable to identify patients’ difficulties with medication administration. MATERIALS AND METHODS: We used a consecutive five-step process to draft key questions regarding 43 aspects of medication administration that can be difficult for patients who manage a complex drug treatment: Step 1) Identification of potentially error-prone characteristics of drug treatment (such as certain dosage forms) and initial draft of key questions. Step 2) Assessment of how comprehensible the questions are for patients. Step 3) Pre-testing of exemplary key questions with patients and monitoring of patient’s actual medication administration behavior. Step 4) Evaluation by general practitioners of how well the questions may be integrated into actual patient visits. Step 5) Final approval of the questions in an expert panel. Thereafter, we pilot-tested exemplary questions with 36 patients (43 tests). In the course of this pilot-testing, the patients’ answers to the key questions were tested against both their actual behavior during medication administration and against their answers to more general questions regarding potential difficulties with medication administration. RESULTS: More than half of the key questions (N = 24/43) were revised at least once during the development process. During the pilot-testing, 55.8% of the pilot-tests (N = 24/43) revealed medication administration difficulties. It was observed that the key questions identified significantly more difficulties (N = 17) than the general questions (N = 8; P = 0.021, positive predictive value = 94.4% vs 88.9%). In one case, both a key question and a general question identified difficulties, which, however, was not confirmed during the drug administration demonstration, indicating a false positive rate of 5.3% in both cases. CONCLUSION: We developed key questions aimed at detecting administration errors with a high specificity and a significantly higher sensitivity than general questions, suggesting that the resource-intensive demonstration of medication administration can be reserved for the detection of rarer and uncommon administration errors. Dove 2021-11-06 /pmc/articles/PMC8579958/ /pubmed/34785891 http://dx.doi.org/10.2147/PPA.S328380 Text en © 2021 Wurmbach et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wurmbach, Viktoria S Schmidt, Steffen J Lampert, Anette Bernard, Simone Faller, Christine K Thürmann, Petra A Haefeli, Walter E Seidling, Hanna M Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title | Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title_full | Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title_fullStr | Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title_full_unstemmed | Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title_short | Development and Pilot-Testing of Key Questions to Identify Patients’ Difficulties in Medication Administration |
title_sort | development and pilot-testing of key questions to identify patients’ difficulties in medication administration |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579958/ https://www.ncbi.nlm.nih.gov/pubmed/34785891 http://dx.doi.org/10.2147/PPA.S328380 |
work_keys_str_mv | AT wurmbachviktorias developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT schmidtsteffenj developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT lampertanette developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT bernardsimone developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT fallerchristinek developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT thurmannpetraa developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT haefeliwaltere developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT seidlinghannam developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration AT developmentandpilottestingofkeyquestionstoidentifypatientsdifficultiesinmedicationadministration |